Correlation Between GlaxoSmithKline PLC and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and TC BioPharm Holdings, you can compare the effects of market volatilities on GlaxoSmithKline PLC and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and TC BioPharm.

Diversification Opportunities for GlaxoSmithKline PLC and TC BioPharm

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between GlaxoSmithKline and TCBP is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and TC BioPharm go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and TC BioPharm

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.19 times more return on investment than TC BioPharm. However, GlaxoSmithKline PLC ADR is 5.27 times less risky than TC BioPharm. It trades about 0.13 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.12 per unit of risk. If you would invest  3,395  in GlaxoSmithKline PLC ADR on November 3, 2024 and sell it today you would earn a total of  132.00  from holding GlaxoSmithKline PLC ADR or generate 3.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  TC BioPharm Holdings

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, GlaxoSmithKline PLC is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.
TC BioPharm Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TC BioPharm Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

GlaxoSmithKline PLC and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and TC BioPharm

The main advantage of trading using opposite GlaxoSmithKline PLC and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind GlaxoSmithKline PLC ADR and TC BioPharm Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
CEOs Directory
Screen CEOs from public companies around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing